Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 2 (RPL36AP2)

Target
RPL36AP2
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L36a pseudogene 2 (RPL36AP2) is classified as a processed pseudogene derived from the ribosomal protein L36a gene. It does not encode a functional protein and is not implicated directly in therapeutic targeting, drug interaction, or disease mechanisms. Like many ribosomal protein pseudogenes, RPL36AP2 originates from genetic duplication or retrotransposition events. Although most pseudogenes are considered non-functional, some may participate in regulatory roles via noncoding RNA mechanisms, such as acting as competitive endogenous RNAs or generating small RNAs that could regulate parental gene expression. However, there is no evidence that RPL36AP2 specifically has any such roles or clinical relevance[1][2][6][10].

Other names
ribosomal protein L36a pseudogene 2RPL36AP2
02

Biological functions

Other (No established protein-coding function; may have potential noncoding RNA regulatory activities like some pseudogenes[6])
03

Disease associations

Other (No direct role established; pseudogenes overall may sometimes be involved in cancer or gene regulation, but there is no specific evidence for RPL36AP2[6])

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 2 (RPL36AP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 2 (RPL36AP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call